Cannabis use in first-treatment bipolar I disorder: Relations to clinical characteristics

Early Intervention in Psychiatry

Volumn 10, Issue 1, 2016, Pages 36-44

  Kvitland, Levi R ^a   Melle, Ingrid ^a   Aminoff, Sofie R ^b   Lagerberg, Trine V ^a   Andreassen, Ole A ^a   Ringen, Petter A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age at onset; Bipolar I; Cannabis; First treatment

Indexed keywords

CANNABIS;

ADOLESCENT; AGE DISTRIBUTION; AGED; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DISEASE SEVERITY; DSM-IV; EDUCATIONAL STATUS; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; INFORMED CONSENT; INTELLIGENCE QUOTIENT; INTERRATER RELIABILITY; INVENTORY OF DEPRESSIVE SYMPTOMS-CLINICIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL HISTORY; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDE ATTEMPT; SYMPTOMATOLOGY; THEMATIC ANALYSIS; TREATMENT DURATION; YOUNG MANIA RATING SCALE; ADULT; BIPOLAR DISORDER; CANNABIS ADDICTION; CASE CONTROL STUDY; COMPLICATION; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGE OF ONSET; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MARIJUANA ABUSE; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84954026070     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12138     Document Type: Article

References (51)

1. Salomon JA, Vos T, Hogan DR etal. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2129-2143.
2. Murray CJ, Vos T, Lozano R etal. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2197-2223.
3. Kroon JS, Wohlfarth TD, Dieleman J etal. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord 2013; 15: 306-313.
4. Lagerberg TV, Sundet K, Aminoff SR etal. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2011; 261: 397-405.
5. Najt P, Fusar-Poli P, Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res 2011; 186: 159-164.
6. Ringen PA, Lagerberg TV, Birkenaes AB etal. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med 2008; 38: 1241-1249.
7. Strakowski SM, DelBello MP, Fleck DE etal. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 2007; 64: 57-64.
8. van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 2007; 102: 1251-1260.
9. De HM, Wampers M, Jendricko T etal. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophr Res 2011; 126: 270-276.
10. Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry 2010; 71: 255-261.
11. Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000; 48: 477-485.
12. Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, Baldessarini RJ. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord 2008; 10: 738-741.
13. Ostacher MJ, Perlis RH, Nierenberg AA etal. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2010; 167: 289-297.
14. Cotton SM, Lambert M, Berk M etal. Gender differences in first episode psychotic mania. BMC Psychiatry 2013; 13: 82.
15. Salvatore P, Baldessarini RJ, Tohen M etal. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry 2011; 72: 183-193.
16. Heffner JL, DelBello MP, Anthenelli RM, Fleck DE, Adler CM, Strakowski SM. Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder. Bipolar Disord 2012; 14: 99-108.
17. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania project. Can J Psychiatry 2009; 54: 105-112.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington: American Psychiatric Association, 1994.
19. First M, Spitzer RL, Gibbon M, Williams J. Structural Clinical Interview for DSM-IV Axis I Disorders - Clinical Version (SCID-CV). Washington DC: American Psychiatric Press, 1997.
20. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18: 65-87.
21. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
22. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
23. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry 2007; 48: 88-94.
24. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
25. Lindenmayer JP, Bossie CA, Kujawa M, Zhu Y, Canuso CM. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale. Psychopathology 2008; 41: 264-270.
26. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). Norwegian Manual Supplement. Stockholm: Pearson Assessment, 2007.
27. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 1998; 79: 163-173.
28. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
29. Ongur D, Lin L, Cohen BM. Clinical characteristics influencing age at onset in psychotic disorders. Compr Psychiatry 2009; 50: 13-19.
30. Kaymaz N, van Os J, de Graaf R, Ten HM, Nolen W, Krabbendam L. The impact of subclinical psychosis on the transition from subclinicial mania to bipolar disorder. J Affect Disord 2007; 98: 55-64.
31. Henquet C, Krabbendam L, de Graaf R, Ten HM, van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 2006; 95: 103-110.
32. Agrawal A, Nurnberger JI Jr, Lynskey MT. Cannabis involvement in individuals with bipolar disorder. Psychiatry Res 2011; 185: 459-461.
33. Lev-Ran S, Le FB, McKenzie K, George TP, Rehm J. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Res 2013; 209: 459-465.
34. Henquet C, van Os J, Kuepper R etal. Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry 2010; 196: 447-453.
35. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry 2005; 162: 1008-1010.
36. Batalla A, Garcia-Rizo C, Castellvi P etal. Screening for substance use disorders in first-episode psychosis: implications for readmission. Schizophr Res 2013; 146: 125-131.
37. Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 2013; 108: 1259-1269.
38. Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry 2013; 202: 172-176.
39. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259-1264.
40. Dekker N, Linszen DH, De HL. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders. Psychopathology 2009; 42: 350-360.
41. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 2001; 50: 71-83.
42. European Monitoring Centre for Drugs and Drug Addiction. A Cannabis Reader: Global Issues and Local Experiences. Lisbon: EMCDDA, 2008.
43. Norwegian Institute for Alcohol and Drug Research. The drug situation in Norway 2010 - annual report to the European Monitoring Centre for Drugs and Drug Addiction - EMCDDA. 2010. SIRUS/EMCDDA. 15-1-2014. Ref Type: Serial (book, monograph).
44. van Rossum I, Boomsma M, Tenback D, Reed C, van Os J. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. J Nerv Ment Dis 2009; 197: 35-40.
45. Azorin JM, Bellivier F, Kaladjian A etal. Characteristics and profiles of bipolar I patients according to age-at-onset: findings from an admixture analysis. J Affect Disord 2013; 150: 993-1000.
46. Etain B, Lajnef M, Bellivier F etal. Clinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United States. J Clin Psychiatry 2012; 73: e561-566.
47. Gonzalez-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry 2010; 43: 263-270.
48. Baldessarini RJ, Bolzani L, Cruz N etal. Onset-age of bipolar disorders at six international sites. J Affect Disord 2010; 121: 143-146.
49. Lieberman DZ, Massey SH, Goodwin FK. The role of gender in single vs married individuals with bipolar disorder. Compr Psychiatry 2010; 51: 380-385.
50. McPherson HM, Dore GM, Loan PA, Romans SE. Socioeconomic characteristics of a Dunedin sample of bipolar patients. N Z Med J 1992; 105: 161-162.
51. Agrawal A, Lynskey MT. Correlates of later-onset cannabis use in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2009; 105: 71-75.